Molecular Quality Controls Market
Report ID: SQMIG35J2410
Report ID: SQMIG35J2410
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35J2410 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
179
|Figures:
79
Global Molecular Quality Controls Market size was valued at USD 245.0 Million in 2024 and is poised to grow from USD 263.38 Million in 2025 to USD 469.72 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).
The primary driver of the molecular quality controls market is the rapid expansion of molecular diagnostics and the corresponding need for reliable assay validation and proficiency testing. Molecular quality controls encompass standardized reference materials, synthetic controls and proficiency panels that verify performance of PCR, next-generation sequencing and companion diagnostics, and they matter because clinical decisions increasingly hinge on nucleic acid results. Historically the market evolved from simple positive and negative controls toward quantified reference standards and lot-to-lot consistency materials after regulatory emphasis following outbreaks like SARS-CoV-2, with manufacturers, reference labs and suppliers scaling production to meet accreditation requirements globally.
Because regulatory scrutiny and clinical reliance on molecular results intensified after public health crises, manufacturers can develop quantified, commutable controls that mimic patient specimens and thereby capture higher-margin product lines and recurring consumable revenue. For example, laboratories running SARS-CoV-2 PCR and oncology panels depend on synthetic RNA standards and multiplex controls to detect low allele fractions, which creates demand for certified reference materials and customized lot controls. Expansion of decentralized testing and penetration into resource-limited regions prompts instrument vendors and quality providers to bundle controls with assays, improving access while creating service contracts that sustain long-term market growth and adoption.
How is AI improving accuracy in the molecular quality controls market?
Molecular quality controls ensure that diagnostic and therapeutic assays produce reliable results by validating reagents instruments and workflows. AI improves accuracy by learning complex signal patterns flagging subtle anomalies and automating review steps that used to rely on manual inspection. Today AI is used to clean noisy sequencing reads harmonize multi source data and predict assay drift which helps labs meet tighter regulatory expectations and scale testing for advanced therapies. Real world examples include AI driven sequencing analytics and image based QC in digital pathology which reduce repeat testing and speed decision making while keeping results consistent.
Oxford Nanopore Technologies and Lonza May 2026, launched a direct RNA sequencing workflow with machine learning based analysis that consolidates multiple critical quality attributes into one GMP ready approach which streamlines testing and supports faster release decisions while increasing throughput and confidence in mRNA product quality.
Market snapshot - (2026-2033)
Global Market Size
USD 245.0 Million
Largest Segment
Independent Controls
Fastest Growth
Independent Controls
Growth Rate
7.5% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global molecular quality controls market is segmented by product type, technology, analyte type, workflow stage, application, end user and region. Based on product type, the market is segmented into Independent Controls and Instrument-Specific Controls. Based on technology, the market is segmented into PCR-Based Controls, DNA Sequencing & NGS Controls, Digital PCR Controls, Isothermal NAAT Controls and Other Molecular Technologies. Based on analyte type, the market is segmented into Single-Analyte Controls and Multi-Analyte Controls. Based on workflow stage, the market is segmented into Pre-Analytical Controls, Analytical Controls and Post-Analytical Controls. Based on application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, Blood Screening, Companion Diagnostics, Prenatal Testing and Other Applications. Based on end user, the market is segmented into Clinical Laboratories, Diagnostic Laboratories, Hospitals, IVD Manufacturers, Contract Research Organizations (CROs), Academic & Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Instrument-Specific Controls segment dominates because laboratories and assay developers prioritize controls that are tailored to particular instrument platforms, ensuring direct compatibility with proprietary chemistry and software. This alignment reduces assay variability and simplifies validation pathways, which in turn supports regulatory acceptance and routine clinical use. Close vendor support and integrated supply chains further reinforce procurement preference, creating dependable performance outcomes that underpin widespread adoption across testing workflows.
However, Independent Controls are witnessing the strongest growth as laboratories increasingly demand cross platform standardization and workflow flexibility. Third party controls harmonize results across varied instruments and vendors, support multi assay validation, and reduce reliance on single suppliers. Expanding needs for interoperability and external validation are driving market entry by diverse control providers and creating new commercial opportunities.
PCR-Based Controls segment dominates because polymerase chain reaction remains the primary method for many diagnostic assays, generating sustained need for well characterized positive and negative controls that match assay chemistry. Familiar assay formats and broad instrument compatibility simplify implementation and regulatory review, while established production and distribution networks ensure consistent supply. These factors combine to make such controls core to routine quality assurance and performance benchmarking.
Meanwhile, DNA Sequencing & NGS Controls are rapidly expanding due to growing adoption of comprehensive genomic profiling and complex panel assays that require advanced quality assessment. Demand for sophisticated reference materials and coverage quality checks along with regulatory scrutiny and oncology applications is increasing need for specialized controls. These developments are accelerating investment in sequencing control solutions and enabling broader clinical implementation of high complexity testing.
To get detailed segments analysis, Request a Free Sample Report
North America maintains a leading position driven by a well developed healthcare and diagnostics ecosystem, high concentration of assay developers, and a mature network of clinical and reference laboratories that demand rigorous quality assurance. Strong regulatory frameworks and established accreditation bodies create predictable pathways for molecular quality control adoption and standardization. The region benefits from deep collaboration between academic research centers, commercial manufacturers, and public health institutions, fostering rapid validation and uptake of control materials. Robust supply chain capabilities and experienced contract manufacturers support consistent production and distribution. Combined with a culture of early technology adoption and extensive training resources for laboratory personnel, these factors reinforce market concentration and sustained leadership in molecular quality controls.
Molecular Quality Controls Market in the United States is characterized by a dense ecosystem of diagnostic companies, extensive clinical laboratory networks, and influential regulatory authorities that prioritize assay performance verification. High levels of private and institutional investment in assay development and validation foster a steady demand for comprehensive control materials. Strong partnerships between industry and academic centers promote innovative quality control formats and proficiency testing programs. Well established distribution channels and experienced vendors enable rapid deployment across clinical, research, and public health laboratories, supporting market depth and product sophistication.
Molecular Quality Controls Market in Canada is shaped by a publicly oriented healthcare landscape with coordinated provincial laboratory systems and centralized reference facilities that emphasize standardized quality practices. National and provincial programs encourage adoption of validated control materials for diagnostics and surveillance, while collaboration with domestic and international suppliers streamlines access to advanced products. Research institutions and clinical labs engage in cooperative validation studies, supporting localized demand for tailored controls. A focus on accreditation and consistent laboratory training contributes to steady integration of molecular quality assurance solutions.
Europe is experiencing accelerated market expansion due to convergence of regulatory harmonization, strong domestic medtech manufacturing, and rising emphasis on precision medicine across healthcare systems. Investment in laboratory infrastructure and regional initiatives to strengthen diagnostic capacity have elevated demand for reliable quality controls. Leading life science hubs and a dense network of independent and hospital laboratories create diverse application areas for molecular controls, while established in vitro diagnostic firms drive product innovation and standardization. Cross border collaborations, public health preparedness programs, and an expanding portfolio of molecular assays for infectious and genetic testing reinforce market momentum and deepen penetration across both established and emerging national markets.
Molecular Quality Controls Market in Germany benefits from a robust medtech manufacturing base and stringent regulatory expectations that create a strong market for high quality control materials. Clinical laboratories and research institutions demand reliable, well characterized controls to meet accreditation standards and support complex molecular diagnostics. Export oriented suppliers and established proficiency testing providers contribute to a competitive ecosystem, while ongoing collaboration between industry and academic centers sustains innovation in assay validation and quality assurance methodologies.
Molecular Quality Controls Market in the United Kingdom is marked by rapid adoption of advanced molecular diagnostics driven by centralized health system procurement and active genomics and innovation initiatives. Laboratories across public and private sectors seek scalable quality control solutions to support expanding test menus and integration of new technologies. A favorable environment for clinical trials, strong ties between research institutions and commercial developers, and streamlined regulatory interactions support swift market uptake and diversification of control product offerings tailored to local needs.
Molecular Quality Controls Market in France is emerging as demand increases for validated control materials across hospital and reference laboratories, supported by national efforts to strengthen genomic and diagnostic capabilities. Growing collaboration between domestic manufacturers and clinical networks facilitates availability of tailored controls for specific assay classes. Emphasis on laboratory accreditation and quality assurance, coupled with investments in centralized testing infrastructure, is fostering broader integration of molecular quality controls into routine diagnostics and public health surveillance.
Asia Pacific is progressively enhancing its market presence through strategic investments in laboratory infrastructure, expansion of local manufacturing capabilities, and stronger regulatory frameworks that emphasize quality and standardization. Regional governments and private stakeholders are promoting biotechnology and diagnostics sectors, encouraging domestic production of control materials and fostering technology transfer partnerships with established global firms. A rising base of clinical and research laboratories, combined with growing accreditation activity and skills development, supports increased adoption of molecular quality assurance solutions. Collaborative networks across universities, contract developers, and industry are accelerating assay validation and market entry for locally tailored control products, reinforcing the region as an increasingly important contributor to the global supply landscape.
Molecular Quality Controls Market in Japan is characterized by high regulatory standards and a mature diagnostics industry that demands rigorous performance verification for molecular assays. Domestic manufacturers and research institutions emphasize quality assurance and detailed validation studies, leading to sophisticated control product offerings. Clinical laboratories and specialized testing centers integrate advanced controls into routine workflows, while active collaboration with global suppliers and a focus on innovation support continuous refinement of control materials to meet complex diagnostic needs.
Molecular Quality Controls Market in South Korea is driven by a dynamic biotech sector and rapid translation of research into commercial diagnostics, creating strong demand for reliable quality controls. A well developed laboratory accreditation framework and proactive industry support encourage adoption of advanced control solutions. Local manufacturers and contract developers collaborate closely with clinical laboratories to deliver tailored products, while export orientation and technology partnerships help raise production quality and expand market reach across the Asia Pacific region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Adoption Of Molecular Diagnostics
Expansion Of Standardized Control Offerings
High Cost Of Quality Controls
Regulatory Complexity and Fragmentation
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global molecular quality controls market is intensifying as diagnostics firms and specialized suppliers pursue M&A, strategic partnerships, and platform innovation to secure assay validation pipelines. Notable moves include LGC’s 2020 acquisition of The Native Antigen Company, SeraCare’s AccuPlex scale up during COVID, and recent supplier partnerships and product launches by EditCo and ARX Sciences that target CRISPR and specimen collection controls.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, a key driver is the rapid expansion of molecular diagnostics and the consequent need for reliable assay validation, while a second driver is the expansion of standardized control offerings that simplify validation across platforms. A key restraint is the relatively high cost of commercial quality controls, which limits adoption among smaller labs and in resource-limited regions. North America remains the dominating region due to its mature diagnostics ecosystem and regulatory frameworks, and Instrument-Specific Controls are the dominating segment as laboratories prefer vendor-tailored materials to ensure compatibility and streamline regulatory acceptance. Market opportunities include AI-enabled analytics and decentralized testing models.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 245.0 Million |
| Market size value in 2033 | USD 469.72 Million |
| Growth Rate | 7.5% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Molecular Quality Controls Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Molecular Quality Controls Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Molecular Quality Controls Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Molecular Quality Controls Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Molecular Quality Controls Market size was valued at USD 245.0 Million in 2024 and is poised to grow from USD 263.38 Million in 2025 to USD 469.72 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).
Competition in the global molecular quality controls market is intensifying as diagnostics firms and specialized suppliers pursue M&A, strategic partnerships, and platform innovation to secure assay validation pipelines. Notable moves include LGC’s 2020 acquisition of The Native Antigen Company, SeraCare’s AccuPlex scale up during COVID, and recent supplier partnerships and product launches by EditCo and ARX Sciences that target CRISPR and specimen collection controls. 'Bio-Rad Laboratories, Inc.', 'Thermo Fisher Scientific Inc.', 'Danaher Corporation', 'Abbott Laboratories', 'F. Hoffmann-La Roche Ltd.', 'Bio-Techne Corporation', 'QuidelOrtho Corporation', 'Randox Laboratories Ltd.', 'LGC Limited', 'Grifols, S.A.', 'Seegene Inc.', 'Hologic, Inc.', 'Microbix Biosystems Inc.', 'Qnostics Ltd.', 'SERO AS', 'Fortress Diagnostics Ltd.', 'Vircell, S.L.', 'Microbiologics, Inc.', 'SpeeDx Pty. Ltd.', 'Maine Molecular Quality Controls, Inc.'
The broader adoption of molecular diagnostics by clinical laboratories and research centers increases the need for reliable quality controls to ensure assay accuracy and reproducibility across platforms. Quality controls enable laboratories to validate workflows, detect assay drift, and maintain consistent performance during implementation of new tests. This drives procurement of standardized control materials for training, proficiency testing, and routine monitoring. As diagnostic complexity grows, stakeholders prioritize validated controls to protect patient safety, support clinician confidence, and facilitate the expansion of molecular testing services.
Expansion Of Personalized Medicine: Demand for tailored molecular assays in personalized therapy is driving uptake of quality control materials designed for allele-specific, variant-sensitive testing. Manufacturers are developing reference panels and commutable controls that reflect diverse patient genotypes and emerging biomarkers, enabling laboratories to validate assays across clinical contexts. This trend encourages partnerships between control developers and diagnostic firms, accelerates product customization, and expands service offerings such as consultation and lot-matching, ultimately supporting clinical confidence in precision diagnostics and broader adoption of targeted treatment pathways.
Why does North America Dominate the Global Molecular Quality Controls Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
